Selected research
Industry Research
F11R Antibody Industry Research Report 2026
Market perspective
The global F11R Antibody market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for F11R Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for F11R Antibody is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for F11R Antibody is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of F11R Antibody include Thermo Fisher Scientific, Merck, United States Biological, Boster Biological Technology, Sino Biological, Santa Cruz Biotechnology, Proteintech, ProSci and OriGene Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global F11R Antibody market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
F11R Antibody Market by Company
Thermo Fisher Scientific
Merck
United States Biological
Boster Biological Technology
Sino Biological
Santa Cruz Biotechnology
Proteintech
ProSci
OriGene Technologies
NSJ Bioreagents
Miltenyi Biotec
MBL International
HUABIO
G Biosciences
Creative Diagnostics
Creative Biolabs
Bioss
Bio-Rad
Abnova
Abcam
F11R Antibody Segment by Type
Polyclonal
Monoclonal
F11R Antibody Segment by Application
Western Blot
Enzyme Linked Immunosorbent Assay
Immunohistochemistry
Others
F11R Antibody Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global F11R Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of F11R Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of F11R Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of F11R Antibody manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of F11R Antibody by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of F11R Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polyclonal
- Monoclonal
Applications
- Western Blot
- Enzyme Linked Immunosorbent Assay
- Immunohistochemistry
- Others
Companies covered
- Thermo Fisher Scientific
- Merck
- United States Biological
- Boster Biological Technology
- Sino Biological
- Santa Cruz Biotechnology
- Proteintech
- ProSci
- OriGene Technologies
- NSJ Bioreagents
- Miltenyi Biotec
- MBL International
- HUABIO
- G Biosciences
- Creative Diagnostics
- Creative Biolabs
- Bioss
- Bio-Rad
- Abnova
- Abcam
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global F11R Antibody Market Size (2021-2032)
- 2.2.2 Global F11R Antibody Sales (2021-2032)
- 2.2.3 Global F11R Antibody Market Average Price (2021-2032)
- 2.3 F11R Antibody by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Polyclonal
- 2.3.3 Monoclonal
- 2.4 F11R Antibody by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Western Blot
- 2.4.3 Enzyme Linked Immunosorbent Assay
- 2.4.4 Immunohistochemistry
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global F11R Antibody Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global F11R Antibody Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global F11R Antibody Revenue of Manufacturers (2021-2026)
- 3.4 Global F11R Antibody Average Price by Manufacturers (2021-2026)
- 3.5 Global F11R Antibody Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of F11R Antibody, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of F11R Antibody, Product Type & Application
- 3.8 Global Manufacturers of F11R Antibody, Established Date
- 3.9 Global F11R Antibody Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher Scientific
- 4.1.1 Thermo Fisher Scientific Company Information
- 4.1.2 Thermo Fisher Scientific Business Overview
- 4.1.3 Thermo Fisher Scientific F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Scientific F11R Antibody Product Portfolio
- 4.1.5 Thermo Fisher Scientific Recent Developments
- 4.2 Merck
- 4.2.1 Merck Company Information
- 4.2.2 Merck Business Overview
- 4.2.3 Merck F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck F11R Antibody Product Portfolio
- 4.2.5 Merck Recent Developments
- 4.3 United States Biological
- 4.3.1 United States Biological Company Information
- 4.3.2 United States Biological Business Overview
- 4.3.3 United States Biological F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 United States Biological F11R Antibody Product Portfolio
- 4.3.5 United States Biological Recent Developments
- 4.4 Boster Biological Technology
- 4.4.1 Boster Biological Technology Company Information
- 4.4.2 Boster Biological Technology Business Overview
- 4.4.3 Boster Biological Technology F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Boster Biological Technology F11R Antibody Product Portfolio
- 4.4.5 Boster Biological Technology Recent Developments
- 4.5 Sino Biological
- 4.5.1 Sino Biological Company Information
- 4.5.2 Sino Biological Business Overview
- 4.5.3 Sino Biological F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sino Biological F11R Antibody Product Portfolio
- 4.5.5 Sino Biological Recent Developments
- 4.6 Santa Cruz Biotechnology
- 4.6.1 Santa Cruz Biotechnology Company Information
- 4.6.2 Santa Cruz Biotechnology Business Overview
- 4.6.3 Santa Cruz Biotechnology F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Santa Cruz Biotechnology F11R Antibody Product Portfolio
- 4.6.5 Santa Cruz Biotechnology Recent Developments
- 4.7 Proteintech
- 4.7.1 Proteintech Company Information
- 4.7.2 Proteintech Business Overview
- 4.7.3 Proteintech F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Proteintech F11R Antibody Product Portfolio
- 4.7.5 Proteintech Recent Developments
- 4.8 ProSci
- 4.8.1 ProSci Company Information
- 4.8.2 ProSci Business Overview
- 4.8.3 ProSci F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 ProSci F11R Antibody Product Portfolio
- 4.8.5 ProSci Recent Developments
- 4.9 OriGene Technologies
- 4.9.1 OriGene Technologies Company Information
- 4.9.2 OriGene Technologies Business Overview
- 4.9.3 OriGene Technologies F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 OriGene Technologies F11R Antibody Product Portfolio
- 4.9.5 OriGene Technologies Recent Developments
- 4.10 NSJ Bioreagents
- 4.10.1 NSJ Bioreagents Company Information
- 4.10.2 NSJ Bioreagents Business Overview
- 4.10.3 NSJ Bioreagents F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 NSJ Bioreagents F11R Antibody Product Portfolio
- 4.10.5 NSJ Bioreagents Recent Developments
- 4.11 Miltenyi Biotec
- 4.11.1 Miltenyi Biotec Company Information
- 4.11.2 Miltenyi Biotec Business Overview
- 4.11.3 Miltenyi Biotec F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Miltenyi Biotec F11R Antibody Product Portfolio
- 4.11.5 Miltenyi Biotec Recent Developments
- 4.12 MBL International
- 4.12.1 MBL International Company Information
- 4.12.2 MBL International Business Overview
- 4.12.3 MBL International F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 MBL International F11R Antibody Product Portfolio
- 4.12.5 MBL International Recent Developments
- 4.13 HUABIO
- 4.13.1 HUABIO Company Information
- 4.13.2 HUABIO Business Overview
- 4.13.3 HUABIO F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 HUABIO F11R Antibody Product Portfolio
- 4.13.5 HUABIO Recent Developments
- 4.14 G Biosciences
- 4.14.1 G Biosciences Company Information
- 4.14.2 G Biosciences Business Overview
- 4.14.3 G Biosciences F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 G Biosciences F11R Antibody Product Portfolio
- 4.14.5 G Biosciences Recent Developments
- 4.15 Creative Diagnostics
- 4.15.1 Creative Diagnostics Company Information
- 4.15.2 Creative Diagnostics Business Overview
- 4.15.3 Creative Diagnostics F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Creative Diagnostics F11R Antibody Product Portfolio
- 4.15.5 Creative Diagnostics Recent Developments
- 4.16 Creative Biolabs
- 4.16.1 Creative Biolabs Company Information
- 4.16.2 Creative Biolabs Business Overview
- 4.16.3 Creative Biolabs F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Creative Biolabs F11R Antibody Product Portfolio
- 4.16.5 Creative Biolabs Recent Developments
- 4.17 Bioss
- 4.17.1 Bioss Company Information
- 4.17.2 Bioss Business Overview
- 4.17.3 Bioss F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Bioss F11R Antibody Product Portfolio
- 4.17.5 Bioss Recent Developments
- 4.18 Bio-Rad
- 4.18.1 Bio-Rad Company Information
- 4.18.2 Bio-Rad Business Overview
- 4.18.3 Bio-Rad F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Bio-Rad F11R Antibody Product Portfolio
- 4.18.5 Bio-Rad Recent Developments
- 4.19 Abnova
- 4.19.1 Abnova Company Information
- 4.19.2 Abnova Business Overview
- 4.19.3 Abnova F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Abnova F11R Antibody Product Portfolio
- 4.19.5 Abnova Recent Developments
- 4.20 Abcam
- 4.20.1 Abcam Company Information
- 4.20.2 Abcam Business Overview
- 4.20.3 Abcam F11R Antibody Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Abcam F11R Antibody Product Portfolio
- 4.20.5 Abcam Recent Developments
5 Global F11R Antibody Market Scenario by Region
- 5.1 Global F11R Antibody Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global F11R Antibody Sales by Region: 2021-2032
- 5.2.1 Global F11R Antibody Sales by Region: 2021-2026
- 5.2.2 Global F11R Antibody Sales by Region: 2027-2032
- 5.3 Global F11R Antibody Revenue by Region: 2021-2032
- 5.3.1 Global F11R Antibody Revenue by Region: 2021-2026
- 5.3.2 Global F11R Antibody Revenue by Region: 2027-2032
- 5.4 North America F11R Antibody Market Facts & Figures by Country
- 5.4.1 North America F11R Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America F11R Antibody Sales by Country (2021-2032)
- 5.4.3 North America F11R Antibody Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe F11R Antibody Market Facts & Figures by Country
- 5.5.1 Europe F11R Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe F11R Antibody Sales by Country (2021-2032)
- 5.5.3 Europe F11R Antibody Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific F11R Antibody Market Facts & Figures by Country
- 5.6.1 Asia Pacific F11R Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific F11R Antibody Sales by Country (2021-2032)
- 5.6.3 Asia Pacific F11R Antibody Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America F11R Antibody Market Facts & Figures by Country
- 5.7.1 South America F11R Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America F11R Antibody Sales by Country (2021-2032)
- 5.7.3 South America F11R Antibody Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa F11R Antibody Market Facts & Figures by Country
- 5.8.1 Middle East and Africa F11R Antibody Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa F11R Antibody Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa F11R Antibody Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global F11R Antibody Sales by Type (2021-2032)
- 6.1.1 Global F11R Antibody Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global F11R Antibody Sales Market Share by Type (2021-2032)
- 6.2 Global F11R Antibody Revenue by Type (2021-2032)
- 6.2.1 Global F11R Antibody Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global F11R Antibody Revenue Market Share by Type (2021-2032)
- 6.3 Global F11R Antibody Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global F11R Antibody Sales by Application (2021-2032)
- 7.1.1 Global F11R Antibody Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global F11R Antibody Sales Market Share by Application (2021-2032)
- 7.2 Global F11R Antibody Revenue by Application (2021-2032)
- 7.2.1 Global F11R Antibody Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global F11R Antibody Revenue Market Share by Application (2021-2032)
- 7.3 Global F11R Antibody Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 F11R Antibody Value Chain Analysis
- 8.1.1 F11R Antibody Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 F11R Antibody Production Mode & Process
- 8.2 F11R Antibody Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 F11R Antibody Distributors
- 8.2.3 F11R Antibody Customers
9 Global F11R Antibody Analyzing Market Dynamics
- 9.1 F11R Antibody Industry Trends
- 9.2 F11R Antibody Industry Drivers
- 9.3 F11R Antibody Industry Opportunities and Challenges
- 9.4 F11R Antibody Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst